Incannex Healthcare (IXHL) Other Operating Expenses (2024)
Incannex Healthcare (IXHL) posted quarterly Other Operating Expenses of -$1.1 million for Q4 2024.
Incannex Healthcare (IXHL) Other Operating Expenses (2024) Analysis & Trends
Incannex Healthcare (IXHL) has reported Other Operating Expenses for 1 consecutive years, with -$1.1 million the latest figure, recorded in Q4 2024.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$1.1 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$1.1 million (changed N/A YoY) and the FY2025 annual result came in at -$932000.0, down 13.24% from the prior year.
- Other Operating Expenses was little changed at -$1.1 million in Q4 2024 per IXHL's latest filing.
- Over the last five years, Other Operating Expenses for IXHL reached as high as -$1.1 million in Q4 2024 and fell as low as -$1.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.10 Mn |